VolitionRx (VNRX) News Today → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free VNRX Stock Alerts $0.75 -0.13 (-14.53%) (As of 04:31 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12 at 10:32 AM | markets.businessinsider.comVolitionRX earnings preview: what Wall Street is expectingApril 23, 2024 | finance.yahoo.comNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through AntechMarch 28, 2024 | seekingalpha.comVolitionRx Limited (VNRX) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comVolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | msn.comTELA Bio launches Liquifix surgical devices in the U.S.March 20, 2024 | finance.yahoo.comVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in JapanFebruary 2, 2024 | finance.yahoo.comVolition to Share Nu.Q® NETs Strategy Update at Upcoming WebinarJanuary 6, 2024 | proactiveinvestors.comVolitionRx has 'compelling plans' to advance veterinary care in 2024January 4, 2024 | finance.yahoo.comVolition Issues Business Review 2023January 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)November 14, 2023 | finance.yahoo.comVolitionRx Limited Announces Third Quarter 2023 Financial Results and Business UpdateNovember 2, 2023 | finance.yahoo.comVNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & IINovember 1, 2023 | msn.comVolitionRX (VNRX) Price Target Increased by 7.93% to 3.76October 31, 2023 | msn.comEF Hutton Initiates Coverage of VolitionRX (VNRX) with Buy RecommendationOctober 28, 2023 | markets.businessinsider.comCantor Fitzgerald Reaffirms Their Buy Rating on VolitionRX (VNRX)October 19, 2023 | proactiveinvestors.comVolitionRx hails study showing Nu.Q NETs promise as biomarker for septic shockOctober 19, 2023 | finance.yahoo.comMeasuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic ShockOctober 18, 2023 | proactiveinvestors.comVolitionRx welcomes US Ambassador to Belgium for exclusive tour of research facilitiesOctober 18, 2023 | finance.yahoo.comUS Ambassador Adler visits Belgian VolitionOctober 16, 2023 | proactiveinvestors.comVolitionRx to present cancer detection abstracts at European oncology conferenceOctober 16, 2023 | finance.yahoo.comVolition Presents Three Cancer Detection Abstracts at ESMO 2023October 13, 2023 | proactiveinvestors.comVolitionRx holds roundtable on sepsis managementOctober 13, 2023 | finance.yahoo.comVolition Publishes Key Opinion Leader Roundtable Report on NETs in SepsisOctober 4, 2023 | proactiveinvestors.comVolitionRx to unveil new cancer detection method insights at upcoming webinarOctober 2, 2023 | finance.yahoo.comVolition to Reveal New Cancer Detection Method Insights at Upcoming WebinarSeptember 22, 2023 | msn.comVolitionRx, Avalo Therapeutic among healthcare moversSeptember 13, 2023 | finance.yahoo.comVolition Hosts Key Opinion Leader Roundtable on Sepsis ManagementAugust 25, 2023 | finance.yahoo.comVolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters.August 23, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)August 14, 2023 | finance.yahoo.comVolitionRx Limited Announces Second Quarter 2023 Financial Results and Business UpdateAugust 13, 2023 | markets.businessinsider.comHere's what Wall Street expects from VolitionRX's earningsJune 26, 2023 | proactiveinvestors.comVolitionRx: Equity raise reaches US$19.5mln as underwriter...VolitionRx: Equity raise reaches US$19.5mln as underwriter...June 1, 2023 | proactiveinvestors.comVolitionRx Limited prices major public offering to fund research and product developmentJune 1, 2023 | msn.comVolitionRx proposes public offeringMay 12, 2023 | marketwatch.com8-K: VOLITIONRX LTDMay 11, 2023 | proactiveinvestors.comVolitionRx reports cash and cash equivalents of $10M at 1Q-endMay 10, 2023 | msn.comVolitionRX Q1 2023 Earnings PreviewMay 10, 2023 | msn.comVolitionRX's Earnings OutlookApril 26, 2023 | finance.yahoo.comVolitionRx Limited to Host Capital Markets Day at the NYSE on Thursday May 11.March 21, 2023 | markets.businessinsider.comMaxim Group Sticks to Their Buy Rating for VolitionRX (VNRX)March 20, 2023 | benzinga.comVolitionRX Stock (AMEX:VNRX), Guidance and ForecastMarch 10, 2023 | finance.yahoo.comVolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business UpdateMarch 6, 2023 | finance.yahoo.comVolitionRx Limited to Webcast Live at VirtualInvestorConferences.com March 9thFebruary 27, 2023 | finance.yahoo.comVNRX: Nu.Q Vet Cancer Test Being Launched by Supply Agreement Partners Heska and IDEXX; 4.945 million Share Offering Completed to Help Fund Management’s InitiativesFebruary 22, 2023 | finance.yahoo.comVolitionRx Limited Announces Closing of $8.7 Million Underwritten Public Offering of Common StockFebruary 17, 2023 | finance.yahoo.comVolitionRx Limited Announces Pricing of $7.525 Million Underwritten Public Offering of Common StockFebruary 16, 2023 | finance.yahoo.comVolition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska CorporationJanuary 20, 2023 | prnewswire.comVolition to Take Part in Nu.Q® Vet Commercial Strategy WebinarJanuary 8, 2023 | finance.yahoo.comVolition Issues Business Review 2022November 16, 2022 | seekingalpha.comVolitionRX Q3 2022 Earnings Preview Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. VNRX Media Mentions By Week VNRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNRX News Sentiment▼-0.500.57▲Average Medical News Sentiment VNRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNRX Articles This Week▼20▲VNRX Articles Average Week Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Apyx Medical News HCW Biologics News DarioHealth News Vaso News Rockwell Medical News Healthier Choices Management News Adit EdTech Acquisition News InspireMD News Ocuphire Pharma News ARCA biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:VNRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDid Intel Just Dethrone Nvidia?Chaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
